Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$1.41 | -$0.79 | -$1.05 |
| Q2 2026 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q3 2026 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q4 2026 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q1 2027 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q2 2027 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2027 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q4 2027 | 1 | -$0.45 | -$0.45 | -$0.45 |
Biohaven Ltd last posted its earnings results on Monday, November 10th, 2025. The company reported $-1.64 earnings per share for the quarter, topping analysts' consensus estimates of $-1.91 by $0.27. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Biohaven Ltd has generated $-9 earnings per share over the last year ($-9.28 diluted earnings per share) and currently has a price-to-earnings ratio of -1.56. Biohaven Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | -$1.91 | -$1.64 | 0.27 | $375.09 K | $0 |
| 08/11/2025 | Q2 2025 | -$1.94 | -$1.94 | 0 | $1.56 M | $0 |
| 05/12/2025 | Q1 2025 | -$1.67 | -$2.17 | -0.5 | N/A | $0 |
| 03/03/2025 | Q4 2024 | -$1.56 | -$1.85 | -0.29 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$1.70 | -$1.70 | 0 | $1.67 K | $0 |
| 08/09/2024 | Q2 2024 | N/A | -$3.64 | N/A | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$1.50 | -$2.20 | -0.7 | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$1.81 | N/A | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$1.33 | -$1.50 | -0.17 | N/A | $0 |
| 07/31/2023 | Q2 2023 | -$1.24 | -$1.32 | -0.08 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$1.39 | -$1.03 | 0.36 | N/A | $0 |
| 03/23/2023 | Q4 2022 | -$1.24 | -$3.30 | -2.06 | N/A | $0 |
| 11/09/2022 | Q3 2022 | -$2.53 | -$1.75 | 0.78 | N/A | $0 |
| 08/05/2022 | Q2 2022 | -$2.79 | -$5.67 | -2.88 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$2.52 | -$2.71 | -0.19 | N/A | $0 |
| 02/25/2022 | Q4 2021 | -$2.07 | -$1.45 | 0.62 | N/A | $0 |
| 11/09/2021 | Q3 2021 | -$2.44 | -$1.52 | 0.92 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$2.77 | -$3.23 | -0.46 | N/A | $92.93 M |
| 05/10/2021 | Q1 2021 | -$2.92 | -$4.27 | -1.35 | N/A | $43.82 M |
| 03/01/2021 | Q4 2020 | -$2.89 | -$4.49 | -1.6 | N/A | $35.11 M |
In the previous quarter, Biohaven Ltd (:BHVN) reported $-1.64 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.91 by $0.27.
The conference call for Biohaven Ltd's latest earnings report can be listened to online.
The conference call transcript for Biohaven Ltd's latest earnings report can be read online.
Biohaven Ltd (:BHVN) has a recorded net income of $-846,422,000.Biohaven Ltd has generated $-9.28 earnings per share over the last four quarters.
Biohaven Ltd (:BHVN) has a price-to-earnings ratio of -1.56 and price/earnings-to-growth ratio is -1.99.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED